Nuwellis Inc (NUWE) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Nuwellis Inc   (NASDAQ: NUWE)
 

Nuwellis Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Nuwellis Inc 's inventory turnover ratio, the ratio that measures Nuwellis Inc 's ability to manage its supply chain, sequentially decreased to 1.43 in the second quarter 2026, which does not come as a surprise, as the Nuwellis Inc continue to experience headwinds, which also impact its supply chain. Nuwellis Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 255 days, from 239 days, in the Mar 31 2026 quarter.

Within Healthcare sector 268 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1718, from total ranking in the first quarter 2026 at 1861.

NUWE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nuwellis Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUWE Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -14.1 % 1.54 % 11.18 % 17.44 % 3.1 %
Y / Y Cost of Sales Growth -38.59 % -14.1 % -20.37 % 8.58 % 6.53 %
Inventory Turnover Ratio (TTM) 1.43 1.53 1.6 1.74 1.78
NUWE's Total Ranking # 1718 # 1861 # 1698 # 1673 # 1687
Average inventory processing period 255 238 229 210 205
Seq. Inventory Growth -2.08 % -6.86 % -12.75 % 7.94 % 15.75 %
Seq. Cost of Sales Growth -34.49 % -6.62 % -0.26 % 0.65 % -8.36 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 122
Healthcare Sector # 269
Overall Market # 1718

Inventory Turnover Ratio Statistics
High Average Low
2.87 1.56 1.14
(Jun 30 2017)   (Mar 31 2022)



NUWE Company Profile >> Back to NUWE Efficiency Comparisons >> Compare NUWE Inventory Turnover Ratio to its Competitors

Financial Statements
Nuwellis Inc 's Inventories $ 2 Millions Visit NUWE's Balance sheet
Nuwellis Inc 's Cost of Revenues TTM $ 3 Millions Visit NUWE's Income Statement
What are NUWE's Sales? Visit NUWE's Sales by Segment

Other Inventory Turnover Ratios
Nuwellis Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NUWE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NUWE's Competitors
Inventory Turnover Ratio for NUWE's Suppliers
Inventory Turnover Ratio for NUWE's Customers

You may also want to know
NUWE's Sales Growth Rates NUWE's Pe Price to earnings ratio NUWE's Receivables Turnover Ratio NUWE's Stock Quote
NUWE's Net Income Growth Rates NUWE's Ps Price to Sales ratio NUWE's Sales per Employee NUWE's Asset Turnover Ratio
NUWE's Net Margin NUWE's Pb Price to Book ratio NUWE's Financial Strength Ratios NUWE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Bausch Health Companies Inc   3.38 $ 3,783.000  Millions$ 1,120  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions

Date modified: 2026-09-03T12:04:35+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.